Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer
European Journal of Cancer2017Vol. 84, pp. 149–158
Citations Over TimeTop 10% of 2017 papers
Related Papers
- → Fresh from the designation pipeline: orphan drugs recently designated in the European Union (November 2012 – January 2013)(2013)5 cited
- → How Far Have We Come? Challenges to Orphan Drug Access in China, 2011-2017(2019)30 cited
- → FDA Orphan Designations, Approvals, and Regulatory Review Time since the Enactment of the Orphan Drug Act (1983)(2022)
- → HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany(2022)
- → HTA92 A Review and Evaluation of Successfully Reimbursed Orphan and Non-Orphan Drugs in Ireland(2023)